TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro Journal Article
| Authors: | Tremblay, C. L.; Giguel, F.; Chou, T. C.; Dong, H.; Takashima, K.; Hirsch, M. S. |
| Article Title: | TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro |
| Keywords: | unclassified drug; human cell; drug efficacy; human immunodeficiency virus infection; letter; cells, cultured; in vitro study; drug synergism; antiretrovirus agent; proteinase inhibitor; imidazoles; antiviral activity; hiv-1; zidovudine; lamivudine; lamivudine plus zidovudine; indinavir; anti-retroviral agents; rna directed dna polymerase inhibitor; efavirenz; receptors, ccr5; chemokine receptor ccr5 antagonist; efavirenz plus indinavir; enfuvirtide; tak 652 |
| Journal Title: | Antiviral Therapy |
| Volume: | 10 |
| Issue: | 8 |
| ISSN: | 1359-6535 |
| Publisher: | International Medical Press |
| Date Published: | 2005-01-01 |
| Start Page: | 967 |
| End Page: | 968 |
| Language: | English |
| PUBMED: | 16430202 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 13" - "Export Date: 24 October 2012" - "CODEN: ANTHF" - "Source: Scopus" |
